Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT07084272
NCT07084272Not yet recruitingNot Applicable

A Comparison Study of ACD-A and EDTA Anticoagulation of Platelet-rich Plasma: Yields and Platelet Distribution

Harrison, Theodore, M.D.0 sites60 target enrollmentStarted: August 1, 2025Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
60
Primary Endpoint
Platelet yield
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

We will test and compare the platelet distribution after centrifugation and the platelet yield of ACD-A and EDTA anticoagulated blood

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •blood dyscrasias

Outcomes

Primary Outcomes

Platelet yield

Time Frame: 5 months

percent of platelets in PRP compared to original blood sample

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Harrison, Theodore, M.D.
Sponsor Class
Indiv
Responsible Party
Principal Investigator
Principal Investigator

Theodore Harrison, MD

MD

Harrison, Theodore, M.D.

Similar Trials

Completed
Not Applicable
DACAB Trial: Follow-up ExtensionCoronary Artery Bypass GraftingAntiplatelet Therapy
NCT03987373Ruijin Hospital500
Recruiting
Not Applicable
Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCICoronary Artery Disease
NCT04814212North Karelia Central Hospital546
Not yet recruiting
Phase 1/2
Study to compare the amount of bleeding with or without discontinuing blood thinners in patients who required teeth extraction.
CTRI/2021/03/032465Dimple Chandra30
Recruiting
Not Applicable
Effect of Anticoagulant Drug Intervention on Postoperative MALE and MACE in Patients With PADAnticoagulant DrugsAntiplatelet DrugPeripheral Arterial Disease
NCT05852197First Affiliated Hospital of Zhejiang University6,000
Active, not recruiting
Not Applicable
Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)Acute Ischemic StrokeExtracranial AtherosclerosisIntracranial AtherosclerosisCoronary Artery AtherosclerosisPeripheral Artery StenosisAnticoagulantAntiplateletAtrial Fibrillation
NCT04010955Asan Medical Center1,200
PRP Yield and Platelet Distribution With... | Clinical Trial